Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02949024 · ClinicalTrials.gov registry record · Phase 1

Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema

A Phase 1 study of Diabetic Macular Edema, sponsored by Clearside Biomedical.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target
2
Study locations

NCT02949024 is a Phase 1 study of Diabetic Macular Edema that has completed, run by Clearside Biomedical. The registered enrollment target is 20 participants, below the 3,794-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02949024, a Phase 1 study of Diabetic Macular Edema, has completed, sponsored by Clearside Biomedical.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

This study is designed to demonstrate the safety and tolerability of suprachoroidal CLS-TA alone or in combination with intravitreal aflibercept in subjects with diabetic macular edema associated with diabetes mellitus.

Conditions Studied

Diabetic Macular Edema

Interventions

  • DRUG IVT Aflibercept
  • DRUG SC CLS-TA

Study Locations (2)

California

  • Retina Vitreous Associates Medical Group Inc - Mountain View

Texas

  • Retina Consultants of Houston, PA - The Woodlands

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-11-10
Est. Completion 2017-10-17
Phase Phase 1

Sponsor

Clearside Biomedical

14 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02949024

The ClinicalTrials.gov registry entry for NCT02949024 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,794-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (99% lower). The listed sponsor is Clearside Biomedical, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Macular Edema appearing as the primary indexed condition, and to 2 interventions - of which IVT Aflibercept is the first listed.

NCT02949024 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.

Frequently Asked Questions

What is clinical trial NCT02949024 about?

NCT02949024 is a clinical study titled "Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema". This study is designed to demonstrate the safety and tolerability of suprachoroidal CLS-TA alone or in combination with intravitreal aflibercept in subjects with diabetic macular edema associated with diabetes mellitus.

What is the current status of trial NCT02949024?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2016-11-10. Estimated completion is 2017-10-17.

What conditions does trial NCT02949024 study?

This clinical trial studies the following conditions: Diabetic Macular Edema.

What interventions are being tested in trial NCT02949024?

The interventions under investigation include: IVT Aflibercept (DRUG), SC CLS-TA (DRUG).

Who is sponsoring clinical trial NCT02949024?

This trial is sponsored by Clearside Biomedical, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02949024 being conducted?

This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetic Macular Edema

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetic Macular Edema

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.